Companies: 10,795·Total market cap: $144.5T

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGNPFOTCHealthcare● Active

$0.44

+$0.01(+1.36%)

Market Cap$1541620

P/E Ratio—

52W High$0.713

52W Low$0.23

Avg Volume5K

Open$0.44

Beta0.91

Net Income Financials Revenue

Algernon Pharmaceuticals Inc. (AGNPF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AGNPF · net income · updated Jun 15, 2026

Core profitability metrics

AGNPF · net income · margin · TTM · CAGR

Net income was −$1.7M for FY2025 (fiscal year ending 2025-08-31), down 241.1% year-over-year. Net profit margin was —.

FY2025 Net Income−$1.7M▼ -241.1% YoY

Trailing 12M (TTM)−$2.3Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-241.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · AGNPF net income history · AGNPF profit margin

Annual net income data

AGNPF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$1.7M▼ 241.1%—$0

FY2024Loss−$503,000▲ +92.6%—$0

FY2023Loss−$6.8M▼ 12.0%—$0

FY2022Loss−$6.1M▲ +21.7%—$0

FY2021Loss−$7.7M▲ +9.4%—$0

Net income vs peers (Healthcare)

AGNPF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Algernon Pharmaceuticals Inc.YOU

AGNPF

−$1.7M-241.1%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Algernon Pharmaceuticals Inc. (AGNPF) reported net income of −$1.7M for FY2025 (fiscal year ending 2025-08-31), down 241.1% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Algernon Pharmaceuticals Inc. has not yet achieved annual profitability based on available data (11 fiscal years). The company has reported net losses across all available periods.

Algernon Pharmaceuticals Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Algernon Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from AGNPF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

AGNPF net income · 4 questions

Algernon Pharmaceuticals Inc. is not currently profitable on an annual basis. The company reported a net loss of $1.7M for FY2025.

is AGNPF profitabledoes AGNPF make a profitAGNPF profitabilityAGNPF profitable company

▸ Source: FMP /income-statement · GAAP · Algernon Pharmaceuticals Inc. · Algernon Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026